Kate H. Moore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kate H. Moore has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
Katrina Parkin
Department of Urogynaecology, St George Hospital, School of Women's and Children's Health University of New South Wales Sydney Australia
9 shared publicationsWendy Allen
Pelvic Floor Unit, St George Hospital, Gray Street, Kogarah, Sydney, NSW 2217, Australia
6 shared publications- Nevine I. D. Te West
St George Hospital, School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia
5 shared publications Chinmoy Mukerjee
Division of Microbiology, SEALS St. George Hospital Sydney New South Wales Australia
4 shared publicationsColin A. Walsh
Pelvic Floor Unit, St George Hospital, University of New South Wales, Sydney, Australia
4 shared publications- Kylie Jan Mansfield
Graduate School of Medicine, University of Wollongong, Wollongong, Australia
4 shared publications
Latest Publications
- Open Access
- 21 August 2025
- Published by Journal of Biological Methods in Bladder
- Vol. 12 (3) , e21200056
Connexins 43 and 45 hemichannels mediate ATP release in the urinary bladder
Background: Connexin (Cx) proteins form gap junctions between adjacent cells to facilitate intercellular communication and also assemble into hemichannels that release small molecules, including adenosine triphosphate (ATP), into the extracellular microenvironment, where ATP acts on purinergic receptors. Objective: This study investigated the roles of Cx43 and Cx45 as ATP release channels in the urinary bladder. Methods: Porcine bladder tissues and cultured cells were stained for Cx43 and Cx45 using immunofluorescence. Cx43- and Cx45-mediated ATP release in response to hypotonic stretch and extracellular Ca2⁺ depletion was assessed in porcine urothelial, suburothelial, and detrusor muscle cells, as well as in the human RT4 cell line. Results: The expression of Cx43 and Cx45 was Immunohistochemically confirmed in porcine bladder tissue, cultured porcine bladder urothelial cells, suburothelial myofibroblasts, detrusor muscle cells, and the human urothelial RT4 cell line. Hypotonic stretch increased ATP release in all four cell types, with porcine urothelial cells exhibiting a 3.8 ± 1.3-fold and RT4 cells a 2.0 ± 0.5-fold increase relative to control levels. Similarly, depletion of extracellular calcium ions (Ca2+) stimulated ATP release from porcine urothelial cells and RT4 cells, yielding 5.4 ± 2.9-fold and 2.4 ± 0.8-fold increases, respectively. Blockade of Cx43 channels with a Cx43 mimetic peptide (peptide 5) and Cx45 channels with a Cx45 mimetic peptide reduced ATP release induced by stretch and Ca2+ depletion in porcine urothelial cells by 50% and 67%, respectively. These blockers also reduced ATP release in RT4 cells. The contributions of Cx43 and Cx45 to ATP release were less prominent in suburothelial and detrusor muscle cells compared to urothelial cells. Conclusion: These findings highlighted ATP’s role as an autocrine/paracrine signaling molecule acting on purinergic receptors during bladder distension and suggested that Cx hemichannels regulate ATP release through mechanotransduction and Ca2+-sensitive pathways, providing new insights into bladder sensory mechanisms.
- 21 August 2025
- Published by Journal of Biological Methods in Bladder
- Vol. 12 (3) , e21200056
Open AccessConnexins 43 and 45 hemichannels mediate ATP release in the urinary bladder
Background: Connexin (Cx) proteins form gap junctions between adjacent cells to facilitate intercellular communication and also assemble into hemichannels that release small molecules, including adenosine triphosphate (ATP), into the extracellular microenvironment, where ATP acts on purinergic receptors. Objective: This study investigated the roles of Cx43 and Cx45 as ATP release channels in the urinary bladder. Methods: Porcine bladder tissues and cultured cells were stained for Cx43 and Cx45 using immunofluorescence. Cx43- and Cx45-mediated ATP release in response to hypotonic stretch and extracellular Ca2⁺ depletion was assessed in porcine urothelial, suburothelial, and detrusor muscle cells, as well as in the human RT4 cell line. Results: The expression of Cx43 and Cx45 was Immunohistochemically confirmed in porcine bladder tissue, cultured porcine bladder urothelial cells, suburothelial myofibroblasts, detrusor muscle cells, and the human urothelial RT4 cell line. Hypotonic stretch increased ATP release in all four cell types, with porcine urothelial cells exhibiting a 3.8 ± 1.3-fold and RT4 cells a 2.0 ± 0.5-fold increase relative to control levels. Similarly, depletion of extracellular calcium ions (Ca2+) stimulated ATP release from porcine urothelial cells and RT4 cells, yielding 5.4 ± 2.9-fold and 2.4 ± 0.8-fold increases, respectively. Blockade of Cx43 channels with a Cx43 mimetic peptide (peptide 5) and Cx45 channels with a Cx45 mimetic peptide reduced ATP release induced by stretch and Ca2+ depletion in porcine urothelial cells by 50% and 67%, respectively. These blockers also reduced ATP release in RT4 cells. The contributions of Cx43 and Cx45 to ATP release were less prominent in suburothelial and detrusor muscle cells compared to urothelial cells. Conclusion: These findings highlighted ATP’s role as an autocrine/paracrine signaling molecule acting on purinergic receptors during bladder distension and suggested that Cx hemichannels regulate ATP release through mechanotransduction and Ca2+-sensitive pathways, providing new insights into bladder sensory mechanisms.
- Open Access
- 5 March 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1302819
Change in microbiota profile after vaginal estriol cream in postmenopausal women with stress incontinence
Introduction: Vaginal estrogen is a treatment for genitourinary symptoms of menopause (GSM), which comprises vaginal atrophy and urinary dysfunction, including incontinence. Previous studies show that estrogen therapy promotes lactobacilli abundance and is associated with reduced GSM symptoms, including reduction of stress incontinence. However, detailed longitudinal studies that characterize how the microbiome changes in response to estrogen are scarce. We aimed to compare the vaginal microbiota of postmenopausal women, before and 12 weeks after vaginal estrogen cream.Methods: A total of 44 paired samples from 22 postmenopausal women with vaginal atrophy and stress incontinence were collected pre-vaginal estrogens and were compared to 12 weeks post-vaginal estrogen. Microbiota was characterized by 16S rRNA amplicon sequencing and biodiversity was investigated by comparing the alpha- and beta-diversity and potential markers were identified using differential abundance analysis.Results: Vaginal estrogen treatment was associated with a reduction in vaginal pH and corresponded with a significant reduction in alpha diversity of the microbiota. Healthy vaginal community state type was associated with lower mean pH 4.89 (SD = 0.6), in contrast to dysbiotic state which had a higher mean pH 6.4 (SD = 0.74). Women with lactobacilli dominant community pre-treatment, showed stable microbiota and minimal change in their pH. Women with lactobacilli deficient microbiome pre-treatment improved markedly (p = 0.004) with decrease in pH −1.31 and change to heathier community state types.Conclusion: In postmenopausal women with stress incontinence, vaginal estrogen promotes Lactobacillus and Bifidobacterium growth and lowers vaginal pH. Maximum response is seen in those with a dysbiotic vaginal microbiota pre-treatment.
- 5 March 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1302819
Open AccessChange in microbiota profile after vaginal estriol cream in postmenopausal women with stress incontinence
Introduction: Vaginal estrogen is a treatment for genitourinary symptoms of menopause (GSM), which comprises vaginal atrophy and urinary dysfunction, including incontinence. Previous studies show that estrogen therapy promotes lactobacilli abundance and is associated with reduced GSM symptoms, including reduction of stress incontinence. However, detailed longitudinal studies that characterize how the microbiome changes in response to estrogen are scarce. We aimed to compare the vaginal microbiota of postmenopausal women, before and 12 weeks after vaginal estrogen cream.Methods: A total of 44 paired samples from 22 postmenopausal women with vaginal atrophy and stress incontinence were collected pre-vaginal estrogens and were compared to 12 weeks post-vaginal estrogen. Microbiota was characterized by 16S rRNA amplicon sequencing and biodiversity was investigated by comparing the alpha- and beta-diversity and potential markers were identified using differential abundance analysis.Results: Vaginal estrogen treatment was associated with a reduction in vaginal pH and corresponded with a significant reduction in alpha diversity of the microbiota. Healthy vaginal community state type was associated with lower mean pH 4.89 (SD = 0.6), in contrast to dysbiotic state which had a higher mean pH 6.4 (SD = 0.74). Women with lactobacilli dominant community pre-treatment, showed stable microbiota and minimal change in their pH. Women with lactobacilli deficient microbiome pre-treatment improved markedly (p = 0.004) with decrease in pH −1.31 and change to heathier community state types.Conclusion: In postmenopausal women with stress incontinence, vaginal estrogen promotes Lactobacillus and Bifidobacterium growth and lowers vaginal pH. Maximum response is seen in those with a dysbiotic vaginal microbiota pre-treatment.
- Open Access
- 25 February 2023
- Published by Wiley in Neurourology and Urodynamics
- Vol. 42 (4) , 799-806
The effect of 12 weeks of estriol cream on stress urinary incontinence post‐menopause: A prospective multinational observational study
Objective: To quantitate the changes in stress urinary incontinence (SUI) outcome measures after 12 weeks of vaginal estriol cream in women with stress incontinence.Methods: A prospective multicentre observational study conducted in tertiary urogynaecology centers. Postmenopausal women with pure SUI or stress predominant mixed urinary incontinence (MUI), not receiving any other treatment for their incontinence were given written instructions regarding digital application of a standard dose of vaginal estriol cream. Outcomes were measured at baseline and 12 weeks. The primary objective outcome was vaginal pH. The primary subjective outcome was the stress domain of the Urogenital Distress Inventory‐6 (UDI‐6). The secondary objective outcome used was the erect cough stress test. Two quality of life questionnaires and two patient reported outcomes were also included.Results: The 46 postmenopausal recruits had a median age of 62.1 interquartile range (IQR 56.2–65.4). At follow up, the primary subjective outcome SUI domain [UDI‐6] significantly improved from 83.3 (IQR 50–100) to 33.3 (33.3–66.7, p ≤ 0.001) as did vaginal pH [from 5.1 (4.9–5.9) to 4.9 (4.6–5.0] p ≤ 0.001; 18/43 patients (42%) were dry on cough stress test.Conclusions: Twelve weeks of vaginal estriol cream significantly reduced symptoms of stress urinary incontinence in this sample of postmenopausal women.
- 25 February 2023
- Published by Wiley in Neurourology and Urodynamics
- Vol. 42 (4) , 799-806
Open AccessThe effect of 12 weeks of estriol cream on stress urinary incontinence post‐menopause: A prospective multinational observational study
Objective: To quantitate the changes in stress urinary incontinence (SUI) outcome measures after 12 weeks of vaginal estriol cream in women with stress incontinence.Methods: A prospective multicentre observational study conducted in tertiary urogynaecology centers. Postmenopausal women with pure SUI or stress predominant mixed urinary incontinence (MUI), not receiving any other treatment for their incontinence were given written instructions regarding digital application of a standard dose of vaginal estriol cream. Outcomes were measured at baseline and 12 weeks. The primary objective outcome was vaginal pH. The primary subjective outcome was the stress domain of the Urogenital Distress Inventory‐6 (UDI‐6). The secondary objective outcome used was the erect cough stress test. Two quality of life questionnaires and two patient reported outcomes were also included.Results: The 46 postmenopausal recruits had a median age of 62.1 interquartile range (IQR 56.2–65.4). At follow up, the primary subjective outcome SUI domain [UDI‐6] significantly improved from 83.3 (IQR 50–100) to 33.3 (33.3–66.7, p ≤ 0.001) as did vaginal pH [from 5.1 (4.9–5.9) to 4.9 (4.6–5.0] p ≤ 0.001; 18/43 patients (42%) were dry on cough stress test.Conclusions: Twelve weeks of vaginal estriol cream significantly reduced symptoms of stress urinary incontinence in this sample of postmenopausal women.
- Open Access
- 1 January 2023
- Published by AME Publishing Company in Gynecology and Pelvic Medicine
- Vol. 8
A review: patient questions about use of vaginal ring pessaries for prolapse
Editorial Commentary A review: patient questions about use of vaginal ring pessaries for prolapse Kate H. Moore
- 1 January 2023
- Published by AME Publishing Company in Gynecology and Pelvic Medicine
- Vol. 8
Open AccessA review: patient questions about use of vaginal ring pessaries for prolapse
Editorial Commentary A review: patient questions about use of vaginal ring pessaries for prolapse Kate H. Moore
- Open Access
- 1 September 2022
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
- Vol. 16, 100164
Does monthly self-management of vaginal ring pessaries reduce the rate of adverse events? A clinical audit
- 1 September 2022
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
- Vol. 16, 100164
Open AccessDoes monthly self-management of vaginal ring pessaries reduce the rate of adverse events? A clinical audit
- Open Access
Virulence Mechanisms of Common Uropathogens and Their Intracellular Localisation within Urothelial Cells
A recurrent urinary tract infection (UTI) is a common debilitating condition whereby uropathogens are able to survive within the urinary tract. In this study, we aimed to determine if the common uropathogens Escherichia coli, Enterococcus faecalis, and Group B Streptococcus possessed virulence mechanisms that enable the invasion of urothelial cells. Urothelial cells were isolated from women with detrusor overactivity and recurrent UTIs; the intracellular localisation of the uropathogens was determined by confocal microscopy. Uropathogens were also isolated from women with acute UTIs and their intracellular localisation and virulence mechanisms were examined (yeast agglutination, biofilm formation, and haemolysis). Fluorescent staining and imaging of urothelial cells isolated from women with refractory detrusor overactivity and recurrent UTIs demonstrated that all three uropathogens were capable of intracellular colonisation. Similarly, the bacterial isolates from women with acute UTIs were also seen to intracellularly localise using an in vitro model. All Enterococcus and Streptococcus isolates possessed a haemolytic capacity and displayed a strong biofilm formation whilst yeast cell agglutination was unique to Escherichia coli. The expression of virulence mechanisms by these uropathogenic species was observed to correlate with successful urothelial cell invasion. Invasion into the bladder urothelium was seen to be a common characteristic of uropathogens, suggesting that bacterial reservoirs within the bladder contribute to the incidence of recurrent UTIs.
Open AccessVirulence Mechanisms of Common Uropathogens and Their Intracellular Localisation within Urothelial Cells
A recurrent urinary tract infection (UTI) is a common debilitating condition whereby uropathogens are able to survive within the urinary tract. In this study, we aimed to determine if the common uropathogens Escherichia coli, Enterococcus faecalis, and Group B Streptococcus possessed virulence mechanisms that enable the invasion of urothelial cells. Urothelial cells were isolated from women with detrusor overactivity and recurrent UTIs; the intracellular localisation of the uropathogens was determined by confocal microscopy. Uropathogens were also isolated from women with acute UTIs and their intracellular localisation and virulence mechanisms were examined (yeast agglutination, biofilm formation, and haemolysis). Fluorescent staining and imaging of urothelial cells isolated from women with refractory detrusor overactivity and recurrent UTIs demonstrated that all three uropathogens were capable of intracellular colonisation. Similarly, the bacterial isolates from women with acute UTIs were also seen to intracellularly localise using an in vitro model. All Enterococcus and Streptococcus isolates possessed a haemolytic capacity and displayed a strong biofilm formation whilst yeast cell agglutination was unique to Escherichia coli. The expression of virulence mechanisms by these uropathogenic species was observed to correlate with successful urothelial cell invasion. Invasion into the bladder urothelium was seen to be a common characteristic of uropathogens, suggesting that bacterial reservoirs within the bladder contribute to the incidence of recurrent UTIs.
- 27 April 2022
- Published by Springer Nature
- p. 219-228
Recurrent Bacterial Cystitis in Women
- 27 April 2022
- Published by Springer Nature
- p. 35-66
How to Conduct Urodynamic Studies: Essentials of a Good Urodynamic Report
- 27 April 2022
- Published by Springer Nature
- p. 35-66
How to Conduct Urodynamic Studies: Essentials of a Good Urodynamic Report
- 27 April 2022
- Published by Springer Nature
- p. 83-104
Conservative Therapy of Stress Incontinence
- 27 April 2022
- Published by Springer Nature
- p. 187-218
Management of Prolapse